The peroxisome poliferator - Activated receptor-γ2 Pro 12Ala variant: Association with type 2 diabetes and trait differences

Diabetes

Volumn 50, Issue 4, 2001, Pages 886-890

  Douglas, Julie A ^a   Erdos, Michael R ^b   Watanabe, Richard M ^c   Braun, Andi ^d   Johnston, Cristy L ^d   Oeth, Paul ^d   Mohlke, Karen L ^b   Valle, Timo T ^e   Ehnholm, Christian ^e   Buchanan, Thomas A ^c   Bergman, Richard N ^c   Collins, Francis S ^b   Boehnke, Michael ^a   Tuomilehto, Jaakko ^e,f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d SEQUENOM INC   (United States)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; CELL RECEPTOR; INSULIN; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BLOOD PRESSURE; DIABETES MELLITUS; DIET RESTRICTION; GENE FREQUENCY; GENETIC VARIABILITY; GENETICS; MIDDLE AGED; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; REFERENCE VALUE; WEIGHT GAIN;

AGED; BLOOD PRESSURE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GENE FREQUENCY; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; TRANSCRIPTION FACTORS; TRIGLYCERIDES; VARIATION (GENETICS); WEIGHT GAIN;

EID: 0034745184     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.4.886     Document Type: Article

References (19)

1. PPARγ, the ultimate thrifty gene
2. PPAR-γ: Adipogenic regulator and thiazolidinedione receptor
3. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
4. Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
5. Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus
6. The Pro115Gln and Pro12Ala PPAR γ gene mutations in obesity and type 2 diabetes
7. Impact of the peroxisome proliferator activated receptor γ2 Pro12Ala polymorphism on adiposity, lipids, and non-insulin-dependent diabetes mellitus
8. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): Divergent modulating effects on body mass index in obese and lean Caucasian men
9. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
10. The PPARγ2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects
11. The Pro12Ala variant in peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) is associated with measures of obesity in Mexican Americans
12. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
13. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
14. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
15. Mapping genes for NIDDM: Design of the Finland-United States Investigation of NIDDM (FUSION) Genetics Study
16. Lilly Lecture 1989: Toward physiological understanding of glucose tolerance: Minimal-model approach
17. Detecting CFTR gene mutations by using primer oligo base extension and mass spectrometry
18. MALDI on a chip: Analysis of arrays of low-femtomole to subfemtomole quantities of synthetic oligonucleotides and DNA diagnostic products dispensed by a piezoelectric pipette